Autobahn Therapeutics
Biotechnology, 9880 Campus Pt Dr, San Diego, California, 92121, United States, 11-50 Employees
Phone Number: 85*********
Who is AUTOBAHN THERAPEUTICS
Autobahn Therapeutics is focused on improving life health for people affected by CNS disorders by driving the regenerative power of the human body. Altering the progressive and debilitati...
Read More
-
Headquarters: 9880 Campus Pt Dr, San Diego, California, 92121, United States
-
Date Founded: 2017
-
Employees: 11-50
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 8049
Does something look wrong? Fix it. | View contact records from AUTOBAHN THERAPEUTICS
Autobahn Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Autobahn Therapeutics
Answer: Autobahn Therapeutics's headquarters are located at 9880 Campus Pt Dr, San Diego, California, 92121, United States
Answer: Autobahn Therapeutics's phone number is 85*********
Answer: Autobahn Therapeutics's official website is https://autobahntx.com
Answer: Autobahn Therapeutics's revenue is $10 Million to $25 Million
Answer: Autobahn Therapeutics's SIC: 8049
Answer: Autobahn Therapeutics has 11-50 employees
Answer: Autobahn Therapeutics is in Biotechnology
Answer: Autobahn Therapeutics contact info: Phone number: 85********* Website: https://autobahntx.com
Answer: Autobahn Therapeutics is focused on improving life health for people affected by CNS disorders by driving the regenerative power of the human body. Altering the progressive and debilitating course of these conditions by returning the brain to a healthier state will transcend the benefits offered by existing therapies and allow people to live the futures they deserve. CNS drug development has long suffered from limited innovation and high failure rates, especially for drugs that strive to modify the underlying cause of disease. Developing successful therapies requires several factors, including a deep knowledge of underlying disease mechanisms, exceptional chemistry, insights into viable translational models and strategies to match the right patients to the most effective drugs. We have brought these elements together at Autobahn to make a real difference in the lives of people. We are leveraging a deep understanding of validated human biology coupled with a brain-targeting chemistry platform to develop thyroid hormone receptor beta agonist therapies that harness the regenerative power of the human body. Our pipeline is led by ABX-002 for the treatment of multiple sclerosis and adrenomyeloneuropathy (AMN), a rare genetic disorder.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month